Mikko O Laukkanen (M O Laukkanen)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 5

Top Topics

Cardiopulmonary Resuscitation

Amyotrophic Lateral Sclerosis

Tyrosine Kinase

Clinical Decision Support

Top Venues

Antioxidants (Basel, Switzerland)

Oxidative medicine and cellular longevity

ESC heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Alessia Parascandolo, Giulio Benincasa, Francesco Corcione, Mikko O Laukkanen
ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma. Antioxidants (Basel, Switzerland) 13 (1) (2024)
Alessia Parascandolo, Giulio Benincasa, Francesco Corcione, Mikko O Laukkanen
ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma. Antioxidants (Basel, Switzerland) 13 (1) (2024)
Alessia Parascandolo, Mikko O Laukkanen
SOD3 Is a Non-Mutagenic Growth Regulator Affecting Cell Migration and Proliferation Signal Transduction. Antioxidants (Basel, Switzerland) 10 (5) (2021)
Gennaro Alfano, Deasy Ciervo, Teresa Migliore, Antonia Sorbo, Manuela Ariello, Andrea Vitale, Mikko O Laukkanen, Salvatore Del Gaudio
Mortal consequences of a cooperative action between Takotsubo syndrome and increased intracranial pressure. ESC heart failure 7 (3) (2020)
Tetsuro Kamiya, Michael Courtney, Mikko O Laukkanen
Redox-Activated Signal Transduction Pathways Mediating Cellular Functions in Inflammation, Differentiation, Degeneration, Transformation, and Death. Oxidative medicine and cellular longevity 2016 (2016)
M D Castellone, Mikko O Laukkanen, H Teramoto, R Bellelli, G Alì, G Fontanini, M Santoro, J S Gutkind
Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma. Oncogene 34 (13) (2014)